Skip to main content
ORASURE TECHNOLOGIES INC logo

ORASURE TECHNOLOGIES INC — Investor Relations & Filings

Ticker · OSUR ISIN · US68554V1089 LEI · 529900GNNJPNM4XHXQ77 US Manufacturing
Open in API
Filings indexed 1,018 across all filing types
Latest filing 2019-03-29 Capital/Financing Update
Country US United States of America
Listing US OSUR

About ORASURE TECHNOLOGIES INC

https://www.orasure.com/

OraSure Technologies, Inc. develops, manufactures, and distributes diagnostic products and sample collection tools. The company specializes in non-invasive technologies, particularly oral fluid-based solutions, to decentralize diagnostics and improve healthcare access. Its portfolio includes point-of-care and over-the-counter rapid tests for infectious diseases such as HIV and COVID-19. A notable achievement is the development of the first over-the-counter at-home HIV test. Through its subsidiaries, OraSure also provides sample management solutions for the collection of biological samples used in genomic, metabolomic, and microbiome research, serving healthcare providers, researchers, and consumers.

Recent filings

Filing Released Lang Actions
8-K
Capital/Financing Update Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a current report used to announce major events that shareholders should know about. The content specifically details the termination of a material definitive agreement, namely a credit agreement. There are no financial statements or detailed financial data presented, nor is this an annual or quarterly report. The document is short (3164 characters) and focuses on a financing-related event, specifically the termination of a credit agreement. This fits the category of Capital/Financing Update (CAP), which covers updates on company fundraising, financing activities, or capital structure changes. It is not a report publication announcement or regulatory filing fallback because it contains substantive information about a financing event. Therefore, the correct classification is CAP with high confidence.
2019-03-29 English
10-K
Annual Report FY 2018
2019-02-28 English
8-K
Board/Management Information Classification · 95% confidence The document is a Form 8-K filed with the SEC, dated February 11, 2019, by OraSure Technologies, Inc. The content focuses on the approval of an Amended Long-Term Incentive Policy (LTIP) by the Board of Directors, detailing changes in equity awards for senior management and named executive officers. The key item is Item 5.02, which relates to the departure, election, or appointment of directors or officers and compensatory arrangements. There is no financial statement or comprehensive financial data presented, nor is this an earnings release or annual/interim report. The document primarily announces changes in management compensation policy and board-approved incentive plans. According to the filing definitions, announcements about changes in senior management or board-related matters fall under Board/Management Information (MANG). The document is substantive and not a mere announcement of a report, so it is not RPA or RNS. Therefore, the correct classification is MANG with high confidence.
2019-02-14 English
DARUMA CAPITAL MANAGEMENT LLC
Major Shareholding Notification
2019-02-14 English
SC 13G
Major Shareholding Notification
2019-02-14 English
Regulatory Filings 2019
Regulatory Filings
2019-02-14 English

Browse filings by year

18 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.